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Abstract
BACKGROUND: Labeled leukocyte scintigraphy (LS) is considered a valuable tool in preoperative diagnosis of prosthetic joint 
infections (PJI). The aim of this study was to determine the accuracy of LS combined with bone marrow scintigraphy (BMS), 
as well as inflammation markers CRP and WBC, in detecting infection in patients with prosthetic joints. 
MATERIAL AND METHODS: This study included patients suspected of having PJI between January and September 2013 at 
the Vienna General Hospital who underwent imaging with 99mTc-HMPAO labeled autologous leukocytes and subsequent BMS. 
Diagnostic accuracy was assessed in terms of sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV). 
RESULTS: A total of 48 patients were included. The most common joint investigated was knee (25), followed by hip (9), shoulder 
(2), and elbow (1). Other parts of the body investigated included the femur (6), tibia (2), leg (2), and foot (1). The pathogens 
most frequently isolated included Staphylococcus epidermidis and Candida albicans. The sensitivity of LS was 60%, specificity 
97%, PPV 86% and NPV 90%. Overall accuracy was calculated to be 90%.
CONCLUSIONS: This study was able to demonstrate that 99mTc-HMPAO labeled autologous leukocytes in patients presenting 
with symptoms of PJI is accurate. In contrast, however, inflammation markers CRP and WBC are not accurate pre-diagnostic 
markers for PJI.
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Background
Given that life expectancy is gradually increasing, prosthetic 
joint replacement is more frequently being utilized as a way of im-
proving the quality of life in an ever-ageing population [1]. Neverthe-
less, there are risks and complications, as with every surgical proce-
dure. Common complications seen after joint replacement surgery 
include aseptic or mechanical loosening, as well as polyethylene 
wear [2]. While not frequently observed, serious complications, 
such as prosthetic joint infection, can result in significant morbidity, 
prolonged invalidity and hospitalization, as well as decrease in joint 
function, all of which often lead to explantation and subsequent 
re-implantation subsequent to several weeks of antibiotic therapy 
[1, 3]. Following primary hip implantation, there is a 1% rate of 
infection, while a 2% rate of infection has been reported in knee 
prostheses [4]. After revision surgery, these percentages increase to 
about 3% for hip replacements and 5% for knee replacements [4]. 
Prosthetic joint infections (PJI) can be classified into “early” 
(within three months after surgery), “delayed” (between three 
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months to two years) and “late” (after two years) [5]. The two 
most common organisms in PJI include Staphylococcus epider-
midis (31%) and Staphylococcus aureus (20%) [2]. While Staphy-
lococcus aureus is typically seen in “early” joint infections, 
coagulase-negative Staphylococci, Streptococci, Enterococci and 
anaerobes are observed in “late” infections [5]. Several factors that 
predispose individuals to PJI are obesity, poor nutritional status, 
diabetes mellitus, higher age, remote infection, immune suppres-
sion, underlying joint inflammation (such as rheumatoid arthritis, 
psoriasis), and prior joint infection [6, 7].
PJI is defined by major and minor criteria by the Musculoskel-
etal Infection Society (MSIS). Major criteria include: a) presence of 
a sinus tract communicating with the prosthesis or b) two positive 
periprosthetic cultures with phenotypically identical organisms [8]. 
Minor criteria include: 1) raised serum erythrocyte sedimentation 
rate (ESR) and serum C-reactive protein concentration (CRP), 
2) raised synovial WBC count change on leucocyte esterase test strip, 
3) raised synovial polymorphonuclear neutrophil percentage, 
4) positive histological analysis of periprosthetic tissue or 5) a single 
positive culture [8]. Tenacious pain after surgery or a persistent 
marginally elevated CRP result in difficult diagnosis situations [1]. 
Therefore, diagnosis involves a variety of different factors. Firstly, 
thorough clinical histories, including medical, surgical and physical 
examinations deliver excellent initial diagnostic and aid in subse-
quent diagnostic evaluation [1]. Further diagnostic evaluation of 
PJI includes a physical examination, hematological tests including 
inflammation markers [C-reactive protein (CRP), white blood cell 
(WBC) count and erythrocyte sedimentation rate (ESR), interleu-
kin-6], joint aspiration and numerous imaging modalities [1, 9]. 
A normal CRP or ESR cannot completely rule out a low-grade 
infection, given that false negative results can occur following 
long-term antibiotic treatment or in patients with delayed-onset 
infection [9]. Therefore, additional diagnostic examinations, such 
as joint aspiration with a WBC count and differential, gram stain 
and culture, as well as numerous imaging modalities may be re-
quired [1, 9]. Unfortunately, the MSIS criteria lacks a standardized 
diagnostic definition, which could improve diagnostic accuracy in 
studies on PJI [10].
It is well known that bacteria secrete chemotactic factors, such 
as prostaglandins and histamine. The secretion of these factors re-
sults in the recruitment of leukocytes, induction of endothelial activa-
tion and edema. Hence, the persistent recruitment of leukocytes from 
the blood to the periprosthetic tissue is characteristic of an acute or 
sub-acute bacterial infection. Autologous radiolabelled white blood 
cells have a high specificity given that they actively migrate into 
an infected tissue via adherence to vascular endothelium [11]. In 
the infected joint, neutrophils are the predominant labeled circulat-
ing cells in labeled leukocyte scintigraphy (LS) using tracers such 
as 111In-oxine and 99mTc-hexamethyl propyleneamine oxime (HMPAO) [1]. 
Leukocyte labeling was first introduced in 1976 by McAfee 
and Thakur [12]. In the absence of infection or where there is no 
increased bone turnover, there is no accumulation of labeled leuko-
cytes [1]. Therefore, LS is deemed a valuable tool in the diagnosis of 
PJI [1]. Since neutrophils are typically absent in aseptic loosened 
prosthesis, LS should be able to differentiate between an inflamed 
aseptic prosthesis and an infected prosthesis [4]. However, one 
must take into consideration that bone marrow displacement or 
activation through surgery can give rise to a secondary uptake of 
leukocytes around the prosthesis [1]. Consequently, a combination 
of LS with BMS using 99mTc-sulphur-/nanocolloid has been introduced [1]. 
The uptake of sulfur-/nano colloid within 48 hours of bacterial 
seeding is suppressed by low oxygen tension, increased intraos-
seous pressure, acidic pH and vascular insufficiency [13]. Since 
infection, on the one hand, stimulates the uptake of leukocytes, but 
on the other hand, suppresses the uptake of sulfur-/nanocolloid, LS 
and BMS are spatially incongruent in infection [4]. If the uptake of 
the two radiopharmaceuticals is similar or spatially congruent, the 
labeled leukocyte activity is attributable to bone marrow uptake [4]. 
The combination of LS and BMS in detecting infection has a re-
ported accuracy of 86–98% [14–25]. LS has also been employed 
in patients with systemic infections, postoperative infections and 
in fever of unknown origin [26]. The indications for a combination 
imaging LS/BMS include prosthetic joint infection, musculoskeletal 
infections, and neuropathic joint [26].
The aim of this study was to examine imaging of LS combined 
with BMS in their accuracy and reliability in detecting infection in pa-
tients with prosthetic joints. Furthermore, inflammation markers CRP 
and WBC count were analyzed for their accuracy in detecting PJI. 
Material and methods
Patients
This study included a total of 48 patients (23 male, 25 female) 
suspected of having PJI diagnosed according to MSIS criteria by 
orthopedic surgeons between January and September 2013 at 
the Vienna General Hospital. In order to be diagnosed with PJI 
and included into the study, the patients had to fulfill one major 
criterion or three minor MSIS criteria. Each patient suffered from 
symptoms such as pain and swelling. Inflammation markers were 
analyzed in the blood in each patient one to two days before un-
dergoing LS/BMS. All patients underwent antibiotic therapy for at 
least four weeks prior to LS/BMS. Informed consent was obtained 
from all individual participants included in the study, making them 
aware of the procedure they were undergoing, the risks and that 
they released their data to be used in clinical studies. The study 
protocol was approved by the local ethical committee (EK-reference 
number 1948/2013) and the study was carried out according to the 
provisions of the Declaration of Helsinki.
Leukocyte labeling
In each patient, approximately four 20 mL blood vials, each 
anticoagulated with 2 mL acid citrate dextrose (ACD), was filled 
with blood drawn from a peripheral vein. The leukocytes were 
separated and radioactively labeled according to protocol (10 min, 
22°C) using Leuco-scint-kits (Medi-Radiopharma, Hungary). The 
labeled leukocytes were then re-suspended and re-injected into 
a peripheral vein with a delay of no more than 150 minutes [27]. 
The mean administered activity of 99mTc-HMPAO was approximately 
700 MBq. Labeling efficiency ranged between 61 and 85%.
Imaging procedures
After leukocyte labeling with 99mTc-HMPAO, patients underwent 
whole body scintigraphy and local images in both anterior and 
posterior views and if required, lateral views, were recorded with 
a double-headed gamma camera four hours after re-injection. 
Additional local images in the necessary views were taken ap-
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proximately 24 hours following re-injection. In the case of positive 
LS, bone marrow scintigraphy was conducted 48 hours after 
re-injection. Local images were recorded 30 minutes after injection 
of 370 MBq 99mTc-nanocolloid (GE Healthcare AG, Switzerland). The 
same gamma camera was used for all acquisitions. The scans were 
visually analyzed and considered positive when leukocyte uptake 
intensity in the region of interest was present, yet there was no corre-
sponding bone marrow uptake in the same region. The scans were 
considered negative when bone marrow uptake in the region of 
interest corresponded to leucocyte uptake intensity. 
Statistical analysis
Descriptive statistics included the following parameters: age, 
gender, diagnosis, labeling efficiency, infection parameters in blood, 
intraoperative bacterial culture result, intraoperative histological 
culture result and end clinical result. Accuracy was determined in 
terms of sensitivity, specificity, positive predictive value and nega-
tive predictive value. 
P-values < 0.05 were considered statistically significant. 
Analysis of data was performed using SPSS (Statistical Package 
for Social Sciences, Chicago, IL, USA) v19 for Windows.
Results
During the duration of the study period from January to Sep-
tember 2013, 48 patients suspected of having prosthetic joint infec-
tions underwent 99mTc-HMPAO labeled autologous leukocyte imag-
ing. All patients underwent subsequent bacterial and histological 
testing via joint aspiration or operation. Patients’ characteristics are 
provided in Table 1. 
There were ten cases of infection. The most common patho-
gens isolated from the joints included Staphylococcus epider-
midis and Candida albicans. Bacterial testing diagnosed S. epi-
dermidis infections in five patients and C. albicans in one patient. 
Six out of our 48 patients, were determined to be true posi-
tive, 37 true negative, one false positive and four false negative. 
Images are provided in Figure 1 and 2. In order to assess the ac-
curacy of this technique, we calculated sensitivity, specificity, posi-
tive predictive value and negative predictive value. The calculated 
sensitivity of LS was 60%, specificity 97%, PPV 86% and NPV 90%. 
Therefore, overall accuracy was 90%.
After analysis of the patients’ charts, pre-diagnostic testing 
with CRP and WBC was conducted in 43 patients. Mean CRP 
was calculated to be 3,9 mg/dL (cut-off 0,5 mg/dL). Thirty-one of 
our patients had a CRP-level higher than the cut-off, with 12 pa-
tients having a CRP below the cut-off. The sensitivity was calculated 
to be 57%, specificity 28%, PPV 13%, NPV 77% and accuracy 33%. 
On the other hand, three patients had WBC counts higher than the 
cut-off, while the remaining had WBC counts lower than the cut-off. 
WBC count had a sensitivity of 0%, specificity 92%, PPV 0%, NPV 
88% and overall accuracy 82%. 
Discussion
The reported accuracy of LS/BMS ranges from 86–98% of 
patients [14–25]. One of the earliest studies with 30 patients exa- 
mining labeled leukocytes with bone marrow imaging and hip 
arthroplasty by Mulamba et al. [28] observed a 92% sensitivity 
and 100% specificity for diagnosing hip infections. Another study 
of LS/BMS in 72 patients with hip arthroplasty demonstrated 100% 
sensitivity and 97% specificity in diagnosing infection [15]. A review 
examining 59 patients with failed hip- and knee arthroplasties by 
Love at al. [24] reported the sensitivity, specificity and accuracy 
of combined LS/BMS to be 100%, 91%, and 95%, respectively. 
In addition, a study by El Espera et al. [23] determined 80% 
sensitivity, 94% specificity and 91% accuracy in 60 patients with 
knee or hip arthroplasty that received combined LS/BMS. While 
most studies show that combined LS/BMS is highly specific, 
the sensitivity of this method can vary. A study by Pill et al. [29] 
reported only 50% sensitivity in combined LS/BMS. Furthermore, 
while Joseph et al. [21] reported 100% specificity in their patient 
population of 58 patients with total knee or hip arthroplasty, they 
observed only 46% sensitivity for combined LS/BMS. In this study, 
we observed a low sensitivity of 60%. While our sensitivity was low 
compared to most studies, it was higher than a study by Joseph 
et al. [21]. This low sensitivity rate was due to the number of false 
negative results. However, after reviewing the leukocyte scans with 
one of the leading nuclear medicine specialists in this field, our 
false negative rate became 0%. Therefore, our sensitivity would 
therefore be 100%. There are a few reasons as so why the pa-
tients were reported as negative in their leukocyte scans. Firstly, 
after review of the patient’s records, it was determined that all 
patients had received antibiotic therapy (one patient Levofloxacin, 
two patients Cephalexin, one patient Clindamycin) for at least 
four weeks prior to their leukocyte scans. Antibiotic therapy can 
result in clearing of the acute infection, thus making it difficult to 
determine an infection in a leukocyte scan. However, after review 
of all of the patients’ records, it was determined that a total of 24 
patients (six true positive, four false negative, 14 true negative) 
were under antibiotic therapy when they received their leukocyte 
scans. Therefore, antibiotic therapy alone could not be responsible 
for a false negative report, in accordance to other studies [30]. 
Furthermore, when reporting on LS there is a learning curve, which 
must be taken into consideration when starting this procedure in 
a hospital. In our department, LS had not been routinely conducted 
until we began again in January 2013. In our study, we observed 
a high specificity of 97%, which is in accordance with other stud-
ies, despite our small patient population. Our overall accuracy 
Table 1. Patients characteristics
Number of patients 48
Males:Females 25:23
Mean age (years) 60 (range 21–84)
Affected joints (numbers)
     Knee
     Hip
     Shoulder
     Elbow
     Other
25
9
2
1
9
Mean CRP [mg/dl] (range) 3.9 (0.05–13.4)
Mean leukocyte count [G/l] (range) 4.8 (0.09–11.1)
Labeling efficiency range (%) 61–85
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was calculated to be 90%, lying well within the reported values. 
The correlation of our results with histological or bacteriological 
results was possible in all 48 patients. Interestingly in our study, 
six patients only underwent aspiration. Of these six patients, four 
were true negative and two were true positive. The remaining 
42 patients underwent subsequent surgical exploration, all of which 
received both histological and bacteriological testing. Therefore, 
the results of the patients who only received aspiration were not 
related to the false negative or false positive cases. While a re-
cently published systematic review questions the role of nuclear 
medicine in the diagnosis of PJI and calls for comparative as-
sessments of diagnostic performance employing the MSIS criteria 
as a standard reference all while using study designs that minimize 
bias [10], we were nonetheless able to show that LS was accurate 
in our small patient population in patients diagnosed with pros-
thetic joint infection according to the MSIS criteria.
Figure 1. True negative LS: A. WBC after 4h; B. WBC after 24 hours; C. bone marrow
Figure 2. True positive LS: A. WBC after 4h; B. WBC after 24 hours; C. bone marrow
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It has been argued that poor sensitivity can be attributed to 
the chronicity of an infection, as well as non-specific inflamma-
tion [31–33]. While chronic infections are typically characterized 
by less distinct neutrophil recruitment and edema [34], a study 
by Datz et al. [35] that examined the labeled leukocytes in acute 
and chronic infections found no significant statistical difference 
in sensitivity. In non-specific inflammation, neutrophils are gene- 
rally absent [36]. Given that LS is most sensitive in imaging 
neutrophil-dominate responses [36], aseptic inflammation may 
lead to false negative results and a decrease in sensitivity [37]. 
On the other hand, one must also consider the actual interpreta-
tion of the images. An image is deemed as positive when there 
is higher uptake in the region of interest than a predetermined 
reference point [26]. Given that infection stimulates the uptake 
of leukocytes but suppresses the uptake of sulfur colloid in the 
bone marrow, a positive image will be spatially incongruent [1]. 
However, one must keep in consideration that both the activity and 
uptake can vary, as well as the normal distribution of WBC’s in the 
bone marrow [26]. For example, one would expect to see fewer 
WBC’s migrating to the joints of chronic infection. Furthermore, 
uptake depends on the number of WBC’s that migrate to the site 
of infection [26]. 
Despite the high accuracy of this technique, LS has its disad-
vantages, which have to be considered before performing this test. 
First, the procedure is labor intensive. Given that two to three 
technologists are involved in the labeling and imaging processes, 
it can be estimated that a total of 8–10 hours is required from them 
for this technique, over two days. Furthermore, this technique 
is routinely available in all only a few hospitals worldwide. In addi-
tion, it involves contact with blood products, which requires strict 
protocols, such as the use of a laminar flow hood [22, 24, 36]. 
In terms of the inflammation markers WBC count and CRP, 
our study included 43 patients who had pre-diagnostic CRP 
and WBC count analyzed. These patients had a mean CRP of 
3,9 mg/dL (cut-off 0,5 mg/dL). The sensitivity was only 57% and 
specificity 28%, with overall accuracy being 33%. We believe 
that CRP is not an accurate pre-diagnostic marker for PJI. How-
ever, our values are in contrast to a review by Yuan et al. [38] 
that demonstrated that CRP had good diagnostic accuracy for 
periprosthetic infections with a sensitivity of 82% and specifi- 
city of 77%. In addition, a study by Glithero et al. [39] examining 
CRP values in patients with suspected PJI reported a sensitivity, 
specificity and accuracy of 83%, 74%, and 77%, respectively. One 
reason for our low accuracy could be due to our small patient 
population compared to the large ones in both studies. On the 
other hand, the mean WBC count was 4,8 G/l (cut-off 10 G/l). Of 
our patient population, only 3 had increased WBC count, while 
the remaining patients had all a normal WBC count. This study 
demonstrated a sensitivity of 0%, but high specificity of 92% and 
overall accuracy of 82%. Therefore, a normal WBC count could be 
highly specific for the absence of infection. However, we must also 
theorize that WBC count is also not an accurate blood marker for 
diagnosing PJI. This is in accordance to a study by Berbari et al. 
[9] that demonstrated that WBC count has the lowest diagnostic 
accuracy for PJI. While this analysis only investigated serum CRP 
and WBC count, a study by Claassen et al. [40] that assessed 
46 patients with knee arthroplasty and aspiration in 77 cases, 
demonstrated an increase in WBC count in only 7 cases and 
normal levels in the remaining patients [40]. In addition, CRP 
was increased in 33 cases and normal in 44 cases [40]. Similar 
to our study, they also concluded that CRP and WBC are not ac-
curate in diagnosing ongoing infection [40]. 
Future directions in leukocyte labeling according to recently 
published papers include SPECT-CT as an adjunct to scintigraphy, 
as well as 18F-FDG-PET-(CT). Several studies have demonstrated 
positive results in utilizing SPECT-CT in infection diagnostics, given 
the improvement in localization and defining the extent of disease. 
Based on current knowledge, it is supposed that the CT component 
increases sensitivity by accurately localizing the anatomical site of 
infection due to the detection of morphologic abnormalities that are 
parallel to sites of increased activity[41]. For example, Filippi et al. 
[42] improved the accuracy of 99mTc-labeled leukocyte scintigraphy 
from 64% to 100%. Moreover, a recently published study by Kim et 
al. [43], which assessed adding SPECT-CT to 99mTc-HMPAO-labeled 
leukocytes, demonstrated an increase in sensitivity from 82% to 
93.3%, specificity 88% to 93.3%, PPV from 89% to 94.3% and NPV 
80.5% to 92.1% and diagnostic accuracy from 84.8% to 93.3% by 
correctly identifying the site of infection. Furthermore, Graute et al. 
[44] were able to increase sensitivity from 66% to 89% and specifi- 
city from 60% to 73% by combining planar images with SPECT-CT. 
However, one must also take into consideration the high radiation 
emitted by CT. In addition, while the CT component of SPECT-CT 
imaging is thought to increase sensitivity, an increase in sensitivity 
ultimately leads to a decrease in specificity. In terms of the role 
of 18F-FDG PET-(CT) in prosthetic joint infection imaging, several 
studies have been conducted showing varying results. Gravius et 
al. [45] and Basu et al. [46] reported similar sensitivities of 93% 
and 94.7% and specificities of 83% and 88.2%, respectively, in 
detecting infection after total knee arthroplasty. The accuracy of 
detecting infection in a knee prosthesis reported by Zhuang et al. 
[47] was quite low at 77.8%. When it comes to infection following 
hip arthroplasty, the accuracy ranges between 89–95% [47–49]. On 
the other hand, studies have shown contradictory results when it 
comes to 18F-FDG-PET-(CT) in prosthetic joint infection. Stumpe et 
al. [50] and Love et al. [24] reported accuracies of only 69% and 
71% in diagnosing lower joint infections with 18F-FDG, respectively. 
In addition, Garcia-Barrechguren et al. [51] demonstrated a sensiti- 
vity and specificity of 64% and 67%, respectively in patients being 
tested for prosthetic hip infection. Moreover, Stumpe et al. [52] 
and Delank et al. [53] concluded in their studies that 18F-FDG 
PET is not specific for infection. However, a recently published 
meta-analysis reported a pooled sensitivity and specificity of 
86% in 18F-FDG-PET and PET-CT examinations in patients with 
lower extremity prosthetic joint infection [54]. Hence, the high 
specificity in 99mTc-HMPAO labeled autologous leukocytes is of 
greater importance in joint infections and therefore this technique 
is considered the gold standard. In conclusion, while the roles of 
additional SPECT-CT and 18F-FDG-PET-CT look promising in the 
diagnosis of prosthetic joint infection, further studies, especially 
comparative studies between these diagnostic modalities and LS, 
need to be conducted. 
In conclusion, this study was able to demonstrate that scin-
tigraphy with 99mTc-HMPAO labeled autologous leukocytes in 
patients presenting with symptoms of prosthetic joint infection 
is accurate, especially in terms of a high specificity and negative 
predictive value. Inflammation markers CRP and WBC count are 
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not accurate in diagnosing prosthetic joint infections. In accordance 
with other studies, it has been shown that LS combined with BMS 
is a feasible imaging method in patients with infection of prosthetic 
joints and may also be a helpful tool in other infection scenarios.
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